$DJT
Trump Media & Technology Group Corp.

2024 Q3 Form 10-Q Financial Statement

#000114036124036633 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $1.011M $836.9K $0.00
YoY Change
Cost Of Revenue $123.3K $36.20K $41.20K
YoY Change 198.55% -12.14%
Gross Profit $887.6K $800.7K $1.151M
YoY Change -2249.15% -30.43%
Gross Profit Margin 87.8% 95.67%
Selling, General & Admin $17.70M $13.42M $10.39M
YoY Change 52.81% 29.15% 305.86%
% of Gross Profit 1993.8% 1675.86% 902.77%
Research & Development $3.894M $4.862M $2.197M
YoY Change 76.77% 121.24%
% of Gross Profit 438.68% 607.17% 190.93%
Depreciation & Amortization $260.6K $3.700K $16.80K
YoY Change 1672.79% -77.98%
% of Gross Profit 29.36% 0.46% 1.46%
Operating Expenses $21.59M $18.28M $11.81M
YoY Change 35.46% 54.79% 151.13%
Operating Profit -$23.65M -$18.66M -$11.81M
YoY Change 48.41% 58.01% 151.09%
Interest Expense $246.7K -$157.8K $3.620M
YoY Change -93.15% -104.36% 814.14%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$19.25M -$16.37M -$8.189M
YoY Change 70.45% 99.87% 90.15%
Income Tax $0.00 $0.00 $904.5K
% Of Pretax Income
Net Earnings -$19.25M -$16.37M -$9.094M
YoY Change 57.87% 79.99% 109.47%
Net Earnings / Revenue -1904.09% -1955.79%
Basic Earnings Per Share -$0.10 -$0.10 -$0.26
Diluted Earnings Per Share -$0.10 -$0.10 -$0.24
COMMON SHARES
Basic Shares Outstanding 194.7M 176.7M 87.50M
Diluted Shares Outstanding 200.8M 166.7M 87.50M

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $672.9M $344.0M $100.0K
YoY Change 20379.68% 343854.4% 3267.0%
Cash & Equivalents $372.1M $344.0M $84.77K
Short-Term Investments $300.7M
Other Short-Term Assets $9.234M $9.553M $100.0K
YoY Change 9453.4% -58.5%
Inventory
Prepaid Expenses $75.76K
Receivables $14.80K $17.50K
Other Receivables $0.00 $0.00
Total Short-Term Assets $682.1M $353.5M $160.5K
YoY Change 20661.18% 220123.82% -34.19%
LONG-TERM ASSETS
Property, Plant & Equipment $4.791M $2.162M
YoY Change
Goodwill $132.2M
YoY Change
Intangibles $15.81M
YoY Change
Long-Term Investments $307.1M
YoY Change 4.57%
Other Assets
YoY Change
Total Long-Term Assets $155.6M $2.969M $307.1M
YoY Change -49.34% -99.03% 4.56%
TOTAL ASSETS
Total Short-Term Assets $682.1M $353.5M $160.5K
Total Long-Term Assets $155.6M $2.969M $307.1M
Total Assets $837.8M $356.5M $307.3M
YoY Change 169.82% 16.01% 4.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.496M $1.948M
YoY Change
Accrued Expenses $3.293M $3.293M $29.59M
YoY Change -92.46% -88.87% 381.91%
Deferred Revenue $1.960M $2.925M
YoY Change
Short-Term Debt $0.00 $0.00 $4.200M
YoY Change -100.0% -100.0% 829.82%
Long-Term Debt Due $4.750M $0.00
YoY Change
Total Short-Term Liabilities $14.36M $14.30M $37.66M
YoY Change -73.28% -62.04% 446.46%
LONG-TERM LIABILITIES
Long-Term Debt $4.684M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.175M $530.3K $10.10M
YoY Change -78.38% -94.75% 0.37%
Total Long-Term Liabilities $6.859M $530.3K $10.10M
YoY Change -31.84% -94.75% 0.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.36M $14.30M $37.66M
Total Long-Term Liabilities $6.859M $530.3K $10.10M
Total Liabilities $21.22M $14.83M $47.72M
YoY Change -66.75% -68.93% 181.47%
SHAREHOLDERS EQUITY
Retained Earnings -$2.908B -$2.888B -$44.21M
YoY Change 4789.37% 6433.02% 171.82%
Common Stock $3.727B $3.230B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.909M
YoY Change
Treasury Stock Shares
Shareholders Equity $816.5M $341.7M -$44.21M
YoY Change
Total Liabilities & Shareholders Equity $837.8M $356.5M $307.3M
YoY Change 169.82% 16.01% 4.53%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$19.25M -$16.37M -$9.094M
YoY Change 57.87% 79.99% 109.47%
Depreciation, Depletion And Amortization $260.6K $3.700K $16.80K
YoY Change 1672.79% -77.98%
Cash From Operating Activities -$21.89M -$21.44M -$200.0K
YoY Change 1902.37% 10619.15% 5.14%
INVESTING ACTIVITIES
Capital Expenditures $9.889M $2.142M
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$300.7M
YoY Change -8596.68%
Cash From Investing Activities -$310.6M -$2.142M
YoY Change -8876.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 360.7M 93.81M 120.0K
YoY Change 47481.83% 78071.17% -20.9%
NET CHANGE
Cash From Operating Activities -21.89M -21.44M -200.0K
Cash From Investing Activities -310.6M -2.142M
Cash From Financing Activities 360.7M 93.81M 120.0K
Net Change In Cash 28.18M 70.23M -80.00K
YoY Change 779.4% -87881.5% 107.68%
FREE CASH FLOW
Cash From Operating Activities -$21.89M -$21.44M -$200.0K
Capital Expenditures $9.889M $2.142M
Free Cash Flow -$31.78M -$23.58M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
41818800
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3528200
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2888288600
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66770700
CY2024Q1 djt Issuance Of Earnout Shares
IssuanceOfEarnoutShares
40000000
CY2024Q2 djt Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCash
233017500
CY2024Q2 us-gaap Other Assets
OtherAssets
0
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3292900
CY2024Q2 us-gaap Notes Payable
NotesPayable
10103000
CY2024Q2 djt Reverse Recapitalization Net
ReverseRecapitalizationNet
219621600
djt Bonus Expenses Triggered By Merger
BonusExpensesTriggeredByMerger
6130000
CY2024Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
87500000
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
7854534
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136700583
CY2024Q1 djt Escrow Shares Outstanding
EscrowSharesOutstanding
614640
CY2024Q1 djt Escrow Shares Not Outstanding
EscrowSharesNotOutstanding
4667033
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
87500000
CY2024Q2 djt Issuance Of Earnout Shares
IssuanceOfEarnoutShares
40000000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1948000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1600700
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7642900
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
732600
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2024Q2 djt Franchise Tax Payable Current
FranchiseTaxPayableCurrent
508200
CY2023Q4 djt Franchise Tax Payable Current
FranchiseTaxPayableCurrent
0
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10831700
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1600700
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9400000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001849635
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Assets
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Assets
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LiabilitiesCurrent
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Liabilities
CY2024Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Liabilities
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
36200
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
41200
us-gaap Cost Of Revenue
CostOfRevenue
129600
us-gaap Cost Of Revenue
CostOfRevenue
82500
CY2024Q2 us-gaap Gross Profit
GrossProfit
800700
CY2023Q2 us-gaap Gross Profit
GrossProfit
1150900
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Reclassifications</div> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Reclassifications of certain prior period amounts have been made to conform to the current period presentation.</div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; font-style: normal; font-variant: normal; text-transform: none;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. Material estimates and assumptions reflected in the unaudited condensed  consolidated financial statements relate to and include, but are not limited to, the valuation of convertible promissory notes, derivative liabilities, earn-out shares and stock-based compensation.</div>
us-gaap Gross Profit
GrossProfit
1477800
us-gaap Gross Profit
GrossProfit
2225800
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8572500
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210300
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8782800
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-22768100
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-31550900
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-66761900
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327599700
CY2024Q1 djt Adjustments To Additional Paid In Capital Fair Value Earnout Shares
AdjustmentsToAdditionalPaidInCapitalFairValueEarnoutShares
0
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300426000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
84588000
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
219621600
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
210274000
CY2024Q2 djt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
97762300
CY2024Q2 djt Stock Issued During Period Value Issuance Of Earnout Shares
StockIssuedDuringPeriodValueIssuanceOfEarnoutShares
0
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-16368000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
341668300
us-gaap Net Income Loss
NetIncomeLoss
-343967700
us-gaap Net Income Loss
NetIncomeLoss
-22978400
us-gaap Paid In Kind Interest
PaidInKindInterest
2659800
us-gaap Paid In Kind Interest
PaidInKindInterest
22630600
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
225916000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7271100
us-gaap Depreciation
Depreciation
9300
us-gaap Depreciation
Depreciation
33300
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542300
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Share Based Compensation
ShareBasedCompensation
84588000
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7900
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
3200
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5269100
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-63400
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-94500
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1488500
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6200100
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
111000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30754300
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7370900
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2141900
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2200
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2141900
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2200
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
47455000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
djt Proceeds From Merger Related Costs Financing Activities
ProceedsFromMergerRelatedCostsFinancingActivities
233017500
djt Proceeds From Merger Related Costs Financing Activities
ProceedsFromMergerRelatedCostsFinancingActivities
0
djt Proceeds From Warrant Conversion
ProceedsFromWarrantConversion
93805400
djt Proceeds From Warrant Conversion
ProceedsFromWarrantConversion
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
374277900
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
341381700
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7373100
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2572700
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9808400
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
343954400
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2435300
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1897700
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
350426000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
djt Noncash Or Part Noncash Transactions Operating Lease Asset Obtained In Exchange For Operating Lease Obligations
NoncashOrPartNoncashTransactionsOperatingLeaseAssetObtainedInExchangeForOperatingLeaseObligations
542300
djt Noncash Or Part Noncash Transactions Operating Lease Asset Obtained In Exchange For Operating Lease Obligations
NoncashOrPartNoncashTransactionsOperatingLeaseAssetObtainedInExchangeForOperatingLeaseObligations
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1488500
djt Deferred Revenue Reorganization Period
DeferredRevenueReorganizationPeriod
P12M
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2024Q2 djt Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCash
233017500
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
135400
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
126100
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2161900
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29200
CY2024Q2 us-gaap Depreciation
Depreciation
3700
CY2023Q2 us-gaap Depreciation
Depreciation
16800
us-gaap Depreciation
Depreciation
9300
us-gaap Depreciation
Depreciation
33300
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
806600
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
353200
CY2024Q2 djt Lease Right Of Use Asset
LeaseRightOfUseAsset
806600
CY2023Q4 djt Lease Right Of Use Asset
LeaseRightOfUseAsset
353200
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
276900
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160300
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
530300
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
201600
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
807200
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
361900
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
66700
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
44900
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
43200
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
38700
CY2024Q2 us-gaap Lease Cost
LeaseCost
109900
CY2023Q2 us-gaap Lease Cost
LeaseCost
83600
us-gaap Operating Lease Cost
OperatingLeaseCost
111600
us-gaap Operating Lease Cost
OperatingLeaseCost
89700
us-gaap Short Term Lease Cost
ShortTermLeaseCost
81800
us-gaap Short Term Lease Cost
ShortTermLeaseCost
75700
us-gaap Lease Cost
LeaseCost
193400
us-gaap Lease Cost
LeaseCost
165400
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
159300
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
338700
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
189200
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
159300
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
66300
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
912800
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
105600
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
807200
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
98258000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
40700000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
240000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
240000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
98018000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
40460000
CY2024Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2024Q2 djt Debt Instrument Liability Component
DebtInstrumentLiabilityComponent
60783200
CY2023Q4 djt Debt Instrument Liability Component
DebtInstrumentLiabilityComponent
3225200
CY2024Q2 djt Debt Instrument Aggregate Interest Charged
DebtInstrumentAggregateInterestCharged
44781600
CY2023Q4 djt Debt Instrument Aggregate Interest Charged
DebtInstrumentAggregateInterestCharged
42121800
CY2024Q2 djt Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
-542300
CY2023Q4 djt Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
0
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
106107100
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
45347000
CY2024Q2 djt Debt Instrument Conversion Of Debt Into Paid In Capital
DebtInstrumentConversionOfDebtIntoPaidInCapital
106107100
CY2023Q4 djt Debt Instrument Conversion Of Debt Into Paid In Capital
DebtInstrumentConversionOfDebtIntoPaidInCapital
0
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
41818800
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3528200
CY2024Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2024Q2 djt Aggregate Change In Fair Value Of Embedded Derivative
AggregateChangeInFairValueOfEmbeddedDerivative
-207084100
CY2023Q4 djt Aggregate Change In Fair Value Of Embedded Derivative
AggregateChangeInFairValueOfEmbeddedDerivative
18832000
CY2024Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
244318900
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
18402800
CY2024Q2 djt Derivative Liability Conversion Paid In Capital
DerivativeLiabilityConversionPaidInCapital
244318900
CY2023Q4 djt Derivative Liability Conversion Paid In Capital
DerivativeLiabilityConversionPaidInCapital
0
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
17282500
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1120300
CY2024Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12964436
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
djt Number Of Shares Deposited Into Escrow Account
NumberOfSharesDepositedIntoEscrowAccount
4667033
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
11000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q4 djt Common Stock Shares Reclassified
CommonStockSharesReclassified
10000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2024Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
1000000000
CY2024Q1 djt Capital Stock Par Or Stated Value Per Share
CapitalStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18366228
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.5
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y4M24D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3125000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.5
djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
-8526792
djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
11.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
12964436
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P4Y9M25D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
275494265
CY2024Q2 djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriod
12964436
CY2024Q2 djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
11.5
djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms
P4Y9M25D
CY2024Q2 djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable
275494265
djt Number Of Shares Deposited Into Escrow Account
NumberOfSharesDepositedIntoEscrowAccount
4667033
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
18000000
CY2024Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
18000000
djt Loss Contingency Period Of Plaintiff Allegation
LossContingencyPeriodOfPlaintiffAllegation
P6M
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001140361-24-036633-index-headers.html Edgar Link pending
0001140361-24-036633-index.html Edgar Link pending
0001140361-24-036633.txt Edgar Link pending
0001140361-24-036633-xbrl.zip Edgar Link pending
djt-20240630.xsd Edgar Link pending
ef20030085_10q.htm Edgar Link pending
ef20030085_ex31-1.htm Edgar Link pending
ef20030085_ex31-2.htm Edgar Link pending
ef20030085_ex32-1.htm Edgar Link pending
ef20030085_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
djt-20240630_def.xml Edgar Link unprocessable
djt-20240630_lab.xml Edgar Link unprocessable
djt-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ef20030085_10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
djt-20240630_cal.xml Edgar Link unprocessable